Caroline den Hoed

Caroline den Hoed is a Researcher at Erasmus MC, affiliated with the Department of Gastroenterology & Hepatology at Erasmus University Rotterdam. Her work focuses on liver transplantation outcomes, immunosuppressive therapies, and maternal health post-transplant. She has contributed to studies on hepatic encephalopathy treatment, antiplatelet prophylaxis efficacy, and donor/donor graft factors influencing transplant success.

Her research integrates clinical data from multi-center cohorts and systematic reviews, emphasizing real-world applications. Key areas include recurrence risks in colorectal cancer survivors, maternal-fetal outcomes in transplant recipients, and the impact of donor conditions like diabetes on graft survival.

Dr. den Hoed’s work has been recognized with the ILTS Business Practices Quality Improvement Competition (2024). Her contributions span peer-reviewed articles in Clinical Gastroenterology and Hepatology, Liver Transplantation, and European Journal of Gastroenterology and Hepatology.

Her studies often highlight translational research, bridging pharmacology (e.g., tacrolimus effects) with surgical outcomes (e.g., hepatic artery thrombosis prevention). Media engagement includes addressing public health concerns like dietary supplement-induced liver damage.